liraglutide 6 mg/mL
liraglutide · INJECTION, SOLUTION · Cipla USA Inc.
No Recall HistoryCurrently in Shortage
Plain English
liraglutide is a injection, solution containing liraglutide at 6 mg/mL, taken subcutaneous. Manufactured by Cipla USA Inc..
Key Facts
- Brand Name
- liraglutide
- Generic Name
- liraglutide
- NDC Code (Product)
69097-910- Manufacturer
- Cipla USA Inc.
- Strength
- 6 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA217234
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 02/25/2026
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
dyspnoea296 reports
anxiety218 reports
condition aggravated211 reports
nausea186 reports
asthma183 reports
wheezing180 reports
therapeutic product effect incomplete178 reports
hypothyroidism174 reports
vomiting172 reports
obstructive airways disorder171 reports
Frequently Asked Questions
What is liraglutide used for?
liraglutide contains liraglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is liraglutide a controlled substance?
liraglutide is not classified as a controlled substance by the DEA.
What is the generic name for liraglutide?
The generic name for liraglutide is liraglutide. There are 11 other brand versions of liraglutide.
What is the NDC code for liraglutide 6 mg/mL?
The NDC (National Drug Code) for liraglutide 6 mg/mL is 69097-910, listed by Cipla USA Inc..